BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 26631886)

  • 1. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
    Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
    Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
    Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
    Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
    Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.
    Gnemmi V; Leleu X; Provot F; Moulonguet F; Buob D
    Am J Kidney Dis; 2012 Sep; 60(3):487-91. PubMed ID: 22721930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis.
    Gibier JB; Gnemmi V; Glowacki F; Boyle EM; Lopez B; MacNamara E; Hoffmann M; Azar R; Guincestre T; Bourdon F; Copin MC; Buob D
    Mod Pathol; 2018 Mar; 31(3):452-462. PubMed ID: 29052601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease.
    Lorenz EC; Sethi S; Poshusta TL; Ramirez-Alvarado M; Kumar S; Lager DJ; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2010 Apr; 25(4):1340-3. PubMed ID: 20061318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal disease in multiple myeloma].
    Hiromura K; Nojima Y
    Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual morphology of amyloid cast nephropathy in renal biopsy portending poor prognosis.
    Rajagopal MD; Nachiappa Ganesh R; Parameswaran S; Puthiyottil D
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30580293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patients.
    Gran C; Gahrton G; Alici E; Nahi H
    Eur J Haematol; 2018 Apr; 100(4):386-388. PubMed ID: 29226427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
    Leung N; Gertz MA; Zeldenrust SR; Rajkumar SV; Dispenzieri A; Fervenza FC; Kumar S; Lacy MQ; Lust JA; Greipp PR; Witzig TE; Hayman SR; Russell SJ; Kyle RA; Winters JL
    Kidney Int; 2008 Jun; 73(11):1282-8. PubMed ID: 18385667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal proteins and renal disease.
    Kyle RA
    Annu Rev Med; 1994; 45():71-7. PubMed ID: 8198402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?
    Doshi M; Lahoti A; Danesh FR; Batuman V; Sanders PW;
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2288-2294. PubMed ID: 27526707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
    Iványi B
    Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.
    Sethi S; Rajkumar SV; D'Agati VD
    J Am Soc Nephrol; 2018 Jul; 29(7):1810-1823. PubMed ID: 29703839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy.
    Matthai SM; Alexander S; Jacob S; Duhli N; David VG; Varughese S
    Indian J Pathol Microbiol; 2020; 63(3):463-466. PubMed ID: 32769341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
    Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH
    Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kidney damage in multiple myeloma and other monoclonal gammopathies].
    Adam Z; Pour L; Krejcí M; Stĕpánková S; Svobodová I; Veselý K; Hájek R
    Vnitr Lek; 2008 Sep; 54(9):847-61. PubMed ID: 18924346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.